Perspective · 10 Sep 2026
Conference abstractPublished 29 Sep 2014
Cross talk between apoptosis, autophagy and necrosis-pathways involved in treatment of neuroblastoma, an in-vitro study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immunology ranks as one of the most rapidly expanding areas of biomedical science, covering topics from cancer and vaccine research to immune deficiencies and autoimmunity. Neuroblastoma and solid extracranial cancer of childhood with an annual incidence of ~ 9.1 cases per million children is reported. Standard treatments include radiation along with chemotherapy, however results in side effects to children due its acute toxicity. Advances in technology has allowed for search of new nontoxic drugs to be used as a single or multidrug therapy in natural products with almost 60% of drugs approved for cancer treatment being from natural origin. Apoptosis, defined as a controlled suicide program to remove defective cells, without damage to neighboring cells, acts via death receptor (extrinsic) and the mitochondrial (intrinsic) pathway. The mitochondrial pathway, involving loss of mitochondrial membrane potential (Δψm), is regulated through a highly intricate cross-talk, includes caspases 8, 9 and 3 situated at pivotal points of the signaling process. Caspase-8 studies represent a yet unknown pro-apoptotic pathway activated by cytotoxic drugs, and further, it was identified as an important p53 target gene in drug-induced death of cancerous cells. Autophagy, type-II cell death, a catabolic process, is phenotypically characterized by formation of large intracellular vacuoles, termed autophagosomes. It includes sequestration of cellular proteins and organelles in a specific sequence prior to the destruction of the nucleus and has been recognized in various cancer cell types as a response to anticancer therapies. Induction of autophagy, results in post-translational processing of cytosolic-associated microtubule- associated protein-1A/1B light chain 3 (LC3-I; ~17kDa), to autophagosome membrane-bound LC3-phosphatidylethanolamine conjugate (LC3-II; ~19 kDa), leading to formation of autophagosomes. p-coumaric acid (p-CA), a ubiquitous plant phenolic acid, has been proven to render protection against pathological conditions. Studies on p-CA as evaluated for its capacity to induce cytotoxic effect to neuroblastoma, N2a, cells and possible mechanism of its action will be discussed.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Shailasree Sekhar”
